Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$38.9B
sum of reported positions
Reported positions
652
Changes vs prior quarter
791
244 new · 197 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 557 measured positions in 8 quarters, the typical new or larger position finished −1.9 pts against the S&P 500 and 44% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
ISHARES TR | 4.53M | $3.4B | 8.8% |
| 10.9M | $1.08B | 2.8% | |
| 1.49M | $838M | 2.2% | |
| 4.66M | $730M | 1.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $35.4B | $38.9B |
| Positions | 605 | 652 |
| Biggest line | — | ISHARES TR 9% |
| 3.17M |
| $538M |
| 1.4% |
| 1.34M | $499M | 1.3% |
| 1.07M | $424M | 1.1% |
| 1.77M | $422M | 1.1% |
| 2.32M | $409M | 1.1% |
| 23.4M | $371M | 1.0% |
| 775K | $356M | 0.9% |
| 895K | $356M | 0.9% |
| 1.05M | $333M | 0.9% |
| 1.25M | $329M | 0.8% |
| 2.48M | $319M | 0.8% |
| 1.17M | $298M | 0.8% |
| 3.04M | $292M | 0.8% |
| 856K | $283M | 0.7% |
| 1.71M | $282M | 0.7% |
| 291K | $281M | 0.7% |
| 6.81M | $269M | 0.7% |
| 1.85M | $261M | 0.7% |
| 2.73M | $251M | 0.6% |
| 984K | $246M | 0.6% |
| 11.3M | $244M | 0.6% |
Iren (IREN)
550K shares
MetLife (MET)
293K shares
Loar (LOAR)
1.09M → 304K shares (−72%)
RB Global (RBA)
329K → 210K shares (−36%)
GALLAGHER ARTHUR J & CO
170K → 105K shares (−38%)
Entergy (ETR)
178K → 210K shares (+18%)
Terex (TEX)
13K → 332K shares (+2379%)
Duos Technologies Group (DUOT)
1.91M → 2M shares (+5%)
PPL Corporation (PPL)
660K shares
Live Nation Entertainment (LYV)
61K → 130K shares (+114%)
T-Mobile (TMUS)
141K shares
American Electric Power (AEP)
147K → 172K shares (+17%)
Ingersoll Rand (IR)
286K shares
Ally Financial (ALLY)
502K shares
Houlihan Lokey (HLI)
11K → 171K shares (+1484%)
Perpetua Resources (PPTA)
237K → 1.1M shares (+363%)
Etoro Group (ETOR)
571K shares
Genmab A (GMAB)
645K → 804K shares (+25%)
S&P Global (SPGI)
54K shares
Tango Therapeutics (TNGX)
17K → 691K shares (+3919%)
Nexstar Media Group (NXST)
119K shares
Cytokinetics (CYTK)
150K → 250K shares (+67%)
Vaxcyte (PCVX)
436K → 362K shares (−17%)
Healthpeak Properties (DOC)
5.62M → 976K shares (−83%)
Propetro Holding (PUMP)
1.42M shares
